On November 5, Astera Labs, Inc. fell 6.39% in Regular Trading, trading at $205.575 per share, with turnover of $70.3257 million.
The move followed continued post-earnings valuation digestion after the company delivered better-than-expected quarterly results and strong guidance, while a recent target price cut added pressure to near-term sentiment.
Background reports indicate Astera Labs, Inc. posted quarterly revenue of $584.9 million, up 154% year over year, with non-GAAP EPS of $1.32, non-GAAP gross margin of 72.4%, and non-GAAP operating margin of 44.7%; Scorpio became the largest product line, and next-quarter guidance was also above expectations. Even so, investors remained focused on how much high growth had already been priced in. At the same time, one institution lowered its target price to $400 from $500 while maintaining an outperform-equivalent view, offsetting a separate bullish call tied to AI agent-driven interconnect upgrades.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments